Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference

Rhea-AI Summary

Five Prime Therapeutics (NASDAQ: FPRX) announces participation in the Cowen 41^st Annual Health Care Conference on March 4, 2021, at 10:30 a.m. ET. CEO Tom Civik and CMO Helen Collins will engage in a fireside chat. A live audio webcast will be available for replay from the company’s website for 30 days post-conference. As a clinical-stage biotechnology company, Five Prime focuses on developing breakthrough cancer therapies, collaborating with patients and industry partners to improve treatment outcomes.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the Cowen 41^st Annual Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m. ET / 7:30 a.m. PT.

Live audio webcast of the presentation will be accessible and available for replay from the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime Therapeutics

Five Prime is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com.

Source: Five Prime Therapeutics, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210226005663/en/

FAQ

When will Five Prime Therapeutics participate in the Cowen Annual Health Care Conference?

Five Prime Therapeutics will participate in the Cowen 41st Annual Health Care Conference on March 4, 2021.

Who from Five Prime Therapeutics will speak at the conference?

Tom Civik, CEO, and Helen Collins, CMO, will speak at the conference.

How can I access the presentation from Five Prime Therapeutics?

The presentation will be accessible via a live audio webcast on Five Prime's website and will be archived for 30 days.

What is the focus of Five Prime Therapeutics?

Five Prime Therapeutics focuses on developing novel therapies for cancer, targeting difficult scientific challenges and unmet medical needs.